FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems Inc. (NYSE:ABI), today announced that it has commercialized a new analysis system to enable researchers to perform high-sample-throughput genotyping studies that are faster, easier and more cost effective than other commercially available methods. The TaqMan® OpenArray™ Genotyping System provides life scientists with the ease-of-use, accuracy, and reproducibility of Applied Biosystems’ TaqMan® SNP Genotyping Assays and TaqMan® DME Assays in a flexible format. This system expands the potential uses of TaqMan technology across a wide range of genotyping applications, providing an extremely fast, high-sample-throughput validation and screening tool for researchers in agricultural, pharmaceutical, and other commercial industries, as well as academic institutions.
